Trubion Logo
  • ABOUT
    • Company Overview
    • Management
    • Contact Information
  • PRODUCTS
    • Product Strategy
    • Product Candidates
    • TRU-015 (Rheumatoid Arthritis)
    • SBI-087 (Rheumatoid Arthritis)
    • SBI-087 (Systemic Lupus Erythematosus)
    • TRU-016 (B-Cell Malignancies)
    • Product Technology
    • SMIP™ Therapeutics
    • SCORPION™ Therapeutics
    • TRU-ADhanCe™ Technology
    • Patient Center
    • Rheumatoid Arthritis (RA)
    • Leukemia
    • Lymphoma
    • Lupus
  • PARTNERSHIPS
    • Current Partnerships
  • INVESTORS
    • Corporate Governance
    • Stock Information
    • Stock Performance
    • Historic Stock Lookup
    • Investment Calculator
    • Dividend History
    • Analyst Coverage
    • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
    • News & Events
    • Press Releases
    • Events & Presentations
    • Stockholder Services
    • Investor FAQs
    • Contact Us
  • MEDIA
  • CAREERS
    • Joining the Trubion Team
    • Job Openings
    • Culture and Benefits

Documents & Charters

Print Print page     Email Email page

Document View
Audit Committee Charter HTML PDF   31.3 KB
Compensation Committee Charter HTML PDF   26.0 KB
Nominating and Corporate Governance Committee Charter HTML PDF   24.1 KB
Whistleblower Policy HTML PDF   25.2 KB
Corporate Communications Policy HTML PDF   26.4 KB
Code of Business Conduct and Ethics HTML PDF  104.3 KB

Shareholder Tools

  • Briefcase Shareholder Briefcase
  • Printed Materials Virtual Investor Kit
  • Email Alerts Email Alerts
  • Download Center Download Library
  • RSS RSS News Feeds

  • Search Investor Relations


Copyright 2002–2008 Trubion Pharmaceuticals Inc. All rights reserved.

Site Map | Terms of Use